Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1866)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (766)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 341 to 350 of 2387
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)
TA351
22 July 2015
22 July 2015
Cannabidiol for treating seizures caused by tuberous sclerosis complex
TA873
1 March 2023
1 March 2023
Cannabidiol with clobazam for treating seizures associated with Dravet syndrome
TA614
18 December 2019
18 December 2019
Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome
TA615
18 December 2019
18 December 2019
Cannabis-based medicinal products
NG144
11 November 2019
22 March 2021
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer
TA100
26 April 2006
26 April 2006
Capecitabine for the treatment of advanced gastric cancer
TA191
28 July 2010
28 July 2010
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura
TA667
16 December 2020
16 December 2020
Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal)
TA884
3 May 2023
3 May 2023
Cardiac contractility modulation device implantation for heart failure
IPG655
26 June 2019
26 June 2019
Previous page
1
…
33
34
Current page
35
36
37
…
239
Page
35
of
239
Next page
Results per page
10
25
50
All
Back to top